Attitudes and beliefs regarding complementary and alternative medicine in a diverse gynecologic oncology patient population

•Complementary and alternative medicine use among diverse gynecologic oncology patients is less common than expected.•Race and ethnicity influence perceived benefits and barriers to complementary and alternative medicine use.•Higher income patients have fewer barriers to complementary and alternativ...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Gynecologic oncology reports Ročník 48; s. 101232
Hlavní autoři: Miller, Emily A., Beaumont, Shanice, Zhou, Zhen Ni, Brewer, Jesse T., Thomas, Charlene, Chapman-Davis, Eloise, Cantillo, Evelyn, Holcomb, Kevin, Pua, Tara, Frey, Melissa K.
Médium: Journal Article
Jazyk:angličtina
Vydáno: Netherlands Elsevier Inc 01.08.2023
Elsevier
Témata:
Alternative medicine
Attitudes and beliefs
Complementary medicine
Gynecologic cancer
Hematology, Oncology, and Palliative Medicine
Obstetrics and Gynecology
Research Report
Complementary medicine
Alternative medicine
Gynecologic cancer
Attitudes and beliefs
ISSN:2352-5789, 2352-5789
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:•Complementary and alternative medicine use among diverse gynecologic oncology patients is less common than expected.•Race and ethnicity influence perceived benefits and barriers to complementary and alternative medicine use.•Higher income patients have fewer barriers to complementary and alternative medicine use.•Understanding attitudes and beliefs about complementary and alternative medicine promotes patient-centered care. To measure prevalence of complementary and alternative medicine (CAM) use in a diverse gynecologic oncology patient population and evaluate how attitudes and beliefs regarding CAM relate to demographic factors. A validated Attitudes and Beliefs about Complementary and Alternative Medicine (ABCAM) survey was distributed to patients with gynecologic malignancy. Results were evaluated using Pearson's Chi-squared and Fisher's exact tests for categorical variables and Wilcoxon ranks sum and Kruskal-Wallace tests for non-normally distributed variables. One-hundred thirty patients completed the ABCAM survey. Self-reported race and ethnicity included Asian or Pacific Islander (n = 54; 42%), Hispanic/Latino (n = 23; 18%), White (n = 21; 16%), Black or African American (n = 20; 15%), American Indian/Alaska Native (n = 8; 6.2%) and Other (n = 4; 3.1%). Twenty-four respondents (18%) reported use of CAM. There was a significant difference in expected benefits to CAM between respondents of different races/ethnicities (p < 0.001). Black and Asian respondents reported greater expected benefit to CAM. Hispanic/Latino, American Indian/Alaskan Native, and White respondents reported fewer expected benefits. A significant association was found between perceived barriers to CAM and race/ethnicity (p 0.043), with Asian, Hispanic/Latino and White respondents perceiving more barriers while Black and American Indian/Alaskan Natives reported perceiving fewer barriers to CAM. Respondents with incomes greater than $100,000 reported fewer barriers to CAM. Use of CAM among gynecologic oncology patients is lower than previously thought. Income, race, and ethnicity inform patient engagement with CAM and can be used to better tailor the provision of evidence-based CAM interventions to benefit a greater number of gynecologic cancer patients.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2352-5789
2352-5789
DOI:10.1016/j.gore.2023.101232